Search results
Moderna expects CDC to view its RSV vaccine as equal to rival shots
Reuters· 3 days ago, opens new tab said on Thursday it expects U.S. Center for Disease Control and Prevention (CDC)...
Pfizer's Stock Is a Buy. Here Are Six Reasons Why.
Motley Fool via Yahoo Finance· 3 days agoPrevnar: The pneumococcal vaccine should continue being a cash cow for the drugmaker despite potential competition from Merck's vaccine V116 in the adult...
Pfizer’s strong Vyndaqel sales draw attention to rare disease drug’s patent life
BioPharma Dive via Yahoo Finance· 4 days agoSales of the transthyretin amyloidosis treatment widely beat Wall Street forecasts in the first...
Moderna Puts Up Big Quarterly Beat; Could Shares Break Out?
Investor's Business Daily· 3 days agoModerna (MRNA) beat Wall Street's first-quarter expectations Thursday. The Covid vaccine maker came...
Supreme Court Rejects Military Chaplains' Lawsuit Claiming Refusal of COVID-19 Vaccine Hurt Their...
Military.com via Yahoo News· 4 days agoThe justices rejected a petition from 39 military chaplains who said they continue to face...
Pfizer lifts profit view on cost cuts, smaller drop in Paxlovid By Reuters
Investing.com· 4 days agoSales of Padcev, a treatment for advanced bladder cancer Pfizer (NYSE:PFE) gained through its $43...
Pfizer stock gains 7% after earnings beat, company calls dividend 'secure'
Yahoo Finance· 3 days ago[and] we do not believe that COVID upside alone ... is enough to drive shares higher in the...
Pfizer’s 44% Decline In Profits Still Tops Estimates—Stock Bounces From Decade Low
Forbes· 4 days agoPfizer comfortably beat expectations in its quarterly earnings report Wednesday morning, as the...
The images that show the two sides of AstraZeneca’s vaccine ‘miracle’
The Telegraph via Yahoo Finance· 5 days agoJamie Scott is nothing if not a fighter. He must be to have survived a reaction to his Covid-19 ...
Pfizer Shares Jump After Beating Estimates
The Wall Street Journal· 3 days agoPfizer Chief Executive Albert Bourla said in an interview Wednesday he was encouraged but that the company's stock is undervalued.